National Institute of Allergy and Infectious Diseases

Small Trial of Alendronate Impact on the Reservoir of HIV

Phase 2Recruiting202630 people15 Oct 2025clinicaltrials.gov

NCT07144293

Phase 2Completed202582 people27 Aug 2025clinicaltrials.gov

NCT07124559

Phase 1/2Not yet recruiting2026144 people15 Aug 2025clinicaltrials.gov

NCT07113743

Phase 1/2Enrolling by invitation202510 people11 Aug 2025clinicaltrials.gov

NCT06959771

Phase 1/2Recruiting20251 person7 May 2025clinicaltrials.gov

NCT06832189

Phase 1Recruiting202620 people18 Feb 2025clinicaltrials.gov

NCT06325709

Phase 1/2Recruiting202415 people22 Mar 2024clinicaltrials.gov

NCT06280950

Phase 2Recruiting2024340 people28 Feb 2024clinicaltrials.gov

NCT06055608

Phase 2Recruiting2024200 people28 Sept 2023clinicaltrials.gov

NCT06005610

Phase 2Terminated202493 people22 Aug 2023clinicaltrials.gov

NCT05652478

Phase 2Recruiting2026120 people15 Dec 2022clinicaltrials.gov

NCT05616546

CollaboratorPhase 4Recruiting202390 people15 Nov 2022clinicaltrials.gov

Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists

Phase 1/2Recruiting202250 people18 Jul 2022clinicaltrials.gov

NCT05406583

Phase 1Completed202296 people6 Jun 2022clinicaltrials.gov

NCT05294588

CollaboratorPhase 2Completed202265 people24 Mar 2022clinicaltrials.gov

Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)

CollaboratorPhase 2Active, not recruiting2022100 people24 Feb 2022clinicaltrials.gov

NCT05078879

Phase 1Completed20214 people15 Oct 2021clinicaltrials.gov

NCT04760691

CollaboratorPhase 1Completed202113 people18 Feb 2021clinicaltrials.gov

NCT04734652

CollaboratorPhase 2Completed2022122 people2 Feb 2021clinicaltrials.gov

NCT04640168

Phase 3Completed20201,010 people23 Nov 2020clinicaltrials.gov

Nikos Vasilakis

Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI15180719 Sept 2026reporter.nih.gov

MAURICIO Lacerda NOGUEIRA

Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI15180719 Sept 2026reporter.nih.gov

Kathryn Alyce Hanley

Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI15180719 Sept 2026reporter.nih.gov

University of Texas Med Br Galveston

Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI151807US$16.2k19 Sept 2026reporter.nih.gov

Nikos Vasilakis

Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI15180719 Sept 2026reporter.nih.gov

MAURICIO Lacerda NOGUEIRA

Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI15180719 Sept 2026reporter.nih.gov

Kathryn Alyce Hanley

Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI15180719 Sept 2026reporter.nih.gov

University of Texas Med Br Galveston

Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI151807US$21.6k19 Sept 2026reporter.nih.gov

Nikos Vasilakis

Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI15180719 Sept 2026reporter.nih.gov

MAURICIO Lacerda NOGUEIRA

Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI15180719 Sept 2026reporter.nih.gov

Kathryn Alyce Hanley

Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI15180719 Sept 2026reporter.nih.gov

University of Texas Med Br Galveston

Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI151807US$32.4k19 Sept 2026reporter.nih.gov

Nikos Vasilakis

Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI15180719 Sept 2026reporter.nih.gov

MAURICIO Lacerda NOGUEIRA

Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI15180719 Sept 2026reporter.nih.gov

Kathryn Alyce Hanley

Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI15180719 Sept 2026reporter.nih.gov

University of Texas Med Br Galveston

Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI151807US$43.2k19 Sept 2026reporter.nih.gov

Nikos Vasilakis

Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI15180719 Sept 2026reporter.nih.gov

MAURICIO Lacerda NOGUEIRA

Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI15180719 Sept 2026reporter.nih.gov

Kathryn Alyce Hanley

Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI15180719 Sept 2026reporter.nih.gov

University of Texas Med Br Galveston

Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI151807US$108k19 Sept 2026reporter.nih.gov

Physical activity interventions for cardiometabolic and psychosocial outcomes in people living with HIV in sub Saharan Africa: A systematic review

P30AI06035428 Sept 2026pubmed.ncbi.nlm.nih.gov

Age-Related Variations in Clinical and Biochemical Profiles of People Living With HIV

R21AI18675026 Sept 2026pubmed.ncbi.nlm.nih.gov

Increasing Multimorbidity Burden After COVID-19 Infection Among People With and Without HIV in the United States: Insights From the National Clinical Cohort Collaborative (N3C)

K01AI16224718 Sept 2026pubmed.ncbi.nlm.nih.gov